These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 33256676

  • 21. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.
    Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA.
    Am J Hypertens; 2005 Jun; 18(6):805-12. PubMed ID: 15925740
    [Abstract] [Full Text] [Related]

  • 22. A cross-sectional study of the effects of β-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
    Griffin TP, Browne GA, Wall D, Dennedy MC, OʼShea PM.
    J Hypertens; 2016 Feb; 34(2):307-15. PubMed ID: 26867057
    [Abstract] [Full Text] [Related]

  • 23. Screening for primary aldosteronism in a primary care unit.
    Volpe C, Wahrenberg H, Hamberger B, Thorén M.
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):212-9. PubMed ID: 23118039
    [Abstract] [Full Text] [Related]

  • 24. Mineralocorticoid Receptor Antagonists Decrease the Rates of Positive Screening for Primary Aldosteronism.
    Tezuka Y, Turcu AF.
    Endocr Pract; 2020 Dec; 26(12):1416-1424. PubMed ID: 33471733
    [Abstract] [Full Text] [Related]

  • 25. Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes.
    Marathias KP, Lambadiari VA, Markakis KP, Vlahakos VD, Bacharaki D, Raptis AE, Dimitriadis GD, Vlahakos DV.
    Am J Nephrol; 2020 Dec; 51(5):349-356. PubMed ID: 32241009
    [Abstract] [Full Text] [Related]

  • 26. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
    Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F.
    Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
    [Abstract] [Full Text] [Related]

  • 27. PREVELENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION.
    Galati SJ, Cheesman KC, Springer-Miller R, Hopkins SM, Krakoff L, Bagiella E, Zhuk RA, Ying TK, Amer C, Boyajian MK, Inabnet WB, Levine AC.
    Endocr Pract; 2016 Nov; 22(11):1296-1302. PubMed ID: 27893293
    [Abstract] [Full Text] [Related]

  • 28. Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure.
    Reed JW.
    Vasc Health Risk Manag; 2016 Nov; 12():393-405. PubMed ID: 27822054
    [Abstract] [Full Text] [Related]

  • 29. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
    Niizuma S, Nakahama H, Kamide K, Fukuchi K, Iwanaga Y, Nakata H, Yoshihara F, Horio T, Nakamura S, Kawano Y.
    Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
    [Abstract] [Full Text] [Related]

  • 30. Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy.
    Schork A, Saynisch J, Vosseler A, Jaghutriz BA, Heyne N, Peter A, Häring HU, Stefan N, Fritsche A, Artunc F.
    Cardiovasc Diabetol; 2019 Apr 05; 18(1):46. PubMed ID: 30953516
    [Abstract] [Full Text] [Related]

  • 31. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
    Chen WG, Zhou TT, Zhou P, Li XW, Wu Z, Zhang KY, Xing JC.
    Int J Clin Exp Pathol; 2015 Apr 05; 8(6):6901-9. PubMed ID: 26261577
    [Abstract] [Full Text] [Related]

  • 32. Primary aldosteronism in a general population sample. The Czech post-MONICA study.
    Widimský J, Bruthans J, Wohlfahrt P, Krajčoviechová A, Šulc P, Linhart A, Filipovský J, Lánská V, Cífkova R.
    Blood Press; 2020 Jun 05; 29(3):191-198. PubMed ID: 32036692
    [Abstract] [Full Text] [Related]

  • 33. Determining the Prevalence of Primary Aldosteronism in Patients With New-Onset Type 2 Diabetes and Hypertension.
    Hu Y, Zhang J, Liu W, Su X.
    J Clin Endocrinol Metab; 2020 Apr 01; 105(4):. PubMed ID: 32163576
    [Abstract] [Full Text] [Related]

  • 34. Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.
    Yin G, Zhang S, Yan L, Wu M, Xu M, Li F, Cheng H.
    Endocrine; 2012 Aug 01; 42(1):182-9. PubMed ID: 22302679
    [Abstract] [Full Text] [Related]

  • 35. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
    Kietsiriroje N, Wonghirundecha R, Suntornlohanakul O, Murray RD.
    Clin Endocrinol (Oxf); 2020 Mar 01; 92(3):196-205. PubMed ID: 31840266
    [Abstract] [Full Text] [Related]

  • 36. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
    Lonati C, Bassani N, Gritti A, Biganzoli E, Morganti A.
    J Hypertens; 2014 Mar 01; 32(3):627-34. PubMed ID: 24445391
    [Abstract] [Full Text] [Related]

  • 37. Aldosterone-to-Renin Ratio Is Associated with Diabetic Nephropathy in Type 2 Diabetic Patients: A Single-Center Retrospective Study.
    Higa M, Ichijo T, Hirose T.
    Med Sci Monit; 2022 Mar 20; 28():e935615. PubMed ID: 35306503
    [Abstract] [Full Text] [Related]

  • 38. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
    Ríos MC, Izquierdo A, Sotelo M, Honnorat E, Rodríguez Cuimbra S, Catay E, Popescu BM.
    Medicina (B Aires); 2011 Mar 20; 71(6):525-30. PubMed ID: 22167725
    [Abstract] [Full Text] [Related]

  • 39. Does the ratio of serum aldosterone to plasma renin activity predict the efficacy of diuretics in hypertension? Results of RENALDO.
    Parthasarathy HK, Alhashmi K, McMahon AD, Struthers AD, McInnes GT, Ford I, Connell JM, MacDonald TM.
    J Hypertens; 2010 Jan 20; 28(1):170-7. PubMed ID: 20009770
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of aldosterone to direct renin ratio, low renin and related Phenotypes in Afro-Colombian patients with apparent treatment resistant hypertension.
    Durán CE, Bustamante M, Barbosa M, Useche EM, Triviño J, Sandoval L, Moncayo PA, Rivas AM, Zapata JS, Hernández Quintero JD, Meza S, Bolaños JS, Schweineberg J, Mesa L, Posada JG.
    Sci Rep; 2024 Aug 05; 14(1):18091. PubMed ID: 39103362
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.